Objectives:

1. Identify and discuss clinical characteristics of acquired resistance to anti-PD-1 therapy

2. Identify and discuss molecular characteristics of acquired resistance to anti-PD-1 therapy

3. Identify and discuss "inflamed" versus "non-inflamed" phenotypes of NSCLC and their clinical significance. 

 

 

 

 

Session date: 
02/20/2017 - 12:00pm to 1:00pm CST
Location: 
UCMC KCBD
Chicago, IL 60637
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Kevin Wood, MD